44
Pharma & HealthcareAvoid
ABSL Pharma And Healthcare
Aditya Birla Sun Life · Direct–Growth · rank #11 of 19 by Smart Score
Data updated
Trailing returns
1 Year
17.6%
+19.7% vs index
3 Years
21.5%
+11.7% vs index
5 Years
14.4%
+4.9% vs index
Since launch
21.5%
Year-by-year performance
2021
+21.4%-9.3% vs index
2022
-11.3%-15.1% vs index
2023
+39.6%+13.0% vs index
2024
+37.7%+22.0% vs index
2025
-3.1%-10.8% vs index
2026
+20.4%+24.1% vs index
Why this score
ABSL Pharma And Healthcare scores 44/100 — #11 of 19 Pharma & Healthcare fund (Avoid). It stands out for sortino ratio — beating 73% of peers on sortino ratio. The main drag is its 5y return (better than only 28% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
5Y return14.45% · 28th percentile in category
Alpha2.84 · 16th percentile in category
Sortino ratio1.69 · 73rd percentile in category
3Y return21.54% · 41st percentile in category
Volatility15.34 · 41st percentile in category
Sharpe ratio1.10 · 56th percentile in category
Top holdings
1.Torrent Pharmaceuticals Ltd9.57%
2.Sun Pharmaceutical Industries Ltd9.19%
3.Apollo Hospitals Enterprise Ltd6.85%
4.Cipla Ltd5.16%
5.Aurobindo Pharma Ltd4.53%
39 disclosed equity positions · portfolio as of Aug 2026 · weights are % of total corpus.